疤痕子宫剖宫产术中联合应用缩宫素与欣母沛对产后出血量的影响

摘要/Abstract

摘要： 目的探讨疤痕子宫剖宫产术中联合应用缩宫素与欣母沛对产后出血量的影响。方法选择2020年1月~2022年1月新余市人民医院收治的81例疤痕子宫行剖宫术患者为研究对象,按照随机数表法分为A组、B组、C组,各27例。A组采用缩宫素,B组在A组基础上联合欣母沛肌肉注射,C组在A组基础上联合欣母沛宫体注射。分析三组患者产后出血（产后2 h出血量、产后24 h出血量、产后出血率、输血率）情况;比较三组患者产前及产后2 h血常规相关指标[红细胞（RBC）、血红蛋白（HGB）]水平;比较三组患者术后48 h内药物不良反应发生情况差异。结果 B、C组患者产后2 h出血量、产后24 h出血量、产后出血率、输血率均低于A组（P<0.05）;B、C两组间产后2 h出血量、产后24 h出血量、产后出血率、输血率比较,差异无统计学意义（P>0.05）。产后2 h对比产前,三组患者RBC水平均升高（P<0.05）,且B、C组明显高于同一时期A组（P<0.05）,B、C两组产后2 h RBC水平比较,差异无统计学意义（P>0.05）;产后2 h对比产前,三组HGB均降低（P<0.05）,但B、C组HGB下降程度较A组差异有统计学意义（P<0.05）,B、C两组HGB水平比较,差异无统计学意义（P>0.05）。术后48 h内,三组患者各项药物不良反应发生率比较,差异无统计学意义（P>0.05）。结论疤痕子宫剖宫产术中应用缩宫素联合欣母沛,可有效减少患者术后出血量,改善患者RBC和HGB水平,两种给药方式均取得良好效果,且用药安全性良好,有利于预后。

关键词: 疤痕子宫, 剖宫产, 缩宫素, 欣母沛, 产后出血

Abstract: Objective To investigate the effect of combined use of oxytocin and Xinmupei on postpartum hemorrhage during cesarean section of scarred uterus. Methods From January 2020 to January 2022, 81 patients with scarred uterus undergoing cesarean section in Xinyu People's Hospital were selected as the research objects. According to the random number table method, they were divided into group A, group B and group C, 27 cases in each group. Group A was given oxytocin, group B was given intramuscular injection of Xinmupei on the basis of group A, and group C was given intramuscular injection of Xinmupei on the basis of group A. The differences in postpartum hemorrhage (postpartum hemorrhage volume in 2 hours, postpartum hemorrhage volume in 24 hours, postpartum hemorrhage rate, blood transfusion rate) among the three groups were analyzed; the changes of blood routine related indicators [red blood cell (RBC) and hemoglobin (HGB)] before and 2 hours after delivery were compared among the three groups; the differences in the incidence of adverse drug reactions within 48 hours after surgery were compared among the three groups. Results The postpartum hemorrhage volume, 24 h postpartum hemorrhage volume, postpartum hemorrhage rate and blood transfusion rate in groups B and C were lower than those in group A (P<0.05), there was no significant difference in the amount of postpartum hemorrhage at 2 h, the amount of postpartum hemorrhage at 24 h, the rate of postpartum hemorrhage, and the rate of blood transfusion between the two groups (P>0.05). Significantly increased (P<0.05), and groups B and C were significantly higher than group A at the same period (P<0.05), and there was no significant difference in RBC levels between groups B and C at 2 h postpartum (P>0.05). At 2 h postpartum compared with prepartum, HGB in the three groups was significantly decreased (P<0.05), but there was significant difference in the degree of HGB decline in groups B and C compared with group A (P<0.05), and there was no difference in HGB levels between groups B and C. Statistical significance (P>0.05); within 48 hours after operation, there was no significant difference in the incidence of adverse drug reactions among the three groups (P>0.05). Conclusion The application of oxytocin combined with Xinmupei in cesarean section of scarred uterus can effectively reduce the postoperative bleeding volume and improve the levels of RBC and HGB in patients. It is beneficial to its prognosis recovery.

Key words: scarred uterus, cesarean section, oxytocin, Xinmupei, postpartum hemorrhage

中图分类号:

R714

陈琳. 疤痕子宫剖宫产术中联合应用缩宫素与欣母沛对产后出血量的影响[J]. 中华养生保健, 2022, 40(22): 47-49.

CHEN Lin. Influence of Combined Use of Oxytocin and Xinmupei on Postpartum Hemorrhage During Cesarean Section of Scarred Uterus[J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(22): 47-49.

参考文献

[1] 李泽琼,刘光昌,秦先芬,等.B-Lynch缝合术联合卡前列素氨丁三醇预防高危产妇剖宫产术中及产后出血的疗效观察[J].中国妇幼保健,2018,33(21):5017-5020.
[2] 舒敏. 序贯应用米非司酮及米索前列醇终止瘢痕子宫早期妊娠的临床效果观察[J].中国药物与临床,2021,21(5):793-795.
[3] 郑丹丹,盛少琴,俞蕾媛,等.三七重楼生化汤联合子宫瘢痕切除术预防二次剖宫产子宫切口憩室的临床研究[J].浙江中医药大学学报,2021,45(2):179-184.
[4] 张帆,张玲,王志萍.卡孕栓联合Bakri球囊在阴道分娩产后出血患者中的临床效果及对凝血因子Ⅶ和凝血功能参数的影响研究[J].中国妇幼保健,2020,35(12):2197-2199.
[5] 李飞飞,余丽金,刘彬,等.欣母沛联合卡贝缩宫素预防宫缩乏力性产后出血的疗效[J].中国计划生育学杂志,2018,26(10):986-988.
[6] 金贝,戴菲玲,吴国栋.经阴道超声联合血清巨噬细胞抑制因子-1,妊娠相关血浆蛋白A水平对早期子宫瘢痕妊娠的诊断价值研究[J].中国性科学,2022,31(1):85-89.
[7] 张冬梅. 卡前列甲酯栓联合缩宫素治疗瘢痕子宫合并前置胎盘再次剖宫产对产后出血的影响[J].中国药物与临床,2020,20(24):4123-4124.
[8] 林美美,吕杰强,许林敏.卡前列素氨丁三醇防治瘢痕子宫产后出血效果及对凝血功能影响[J].中国计划生育学杂志,2019,27(8):1011-1014.
[9] 王翠丽,祝妮娜.卡前列素氨丁三醇联合缩宫素对产后出血患者血小板聚集能力及出血量的影响[J].血栓与止血学,2022,28(3):832-833.
[10] 杨艳芬,卢丽敏.欣母沛与马来酸麦角新碱对阴道分娩产后出血的预防效果及子宫复旧的影响[J].中国妇产科临床杂志,2019,20(3): 258-259.
[11] 薛文先. 卡前列素氨丁三醇与米索前列醇分别联合缩宫素在高危剖宫产产妇产后出血防治中的应用[J].中国药物与临床,2020, 20(18):3105-3106.
[12] 韩翠珍,吴瑞花,郭丽丽.足月妊娠引产产妇应用宫颈双球囊扩张联合小剂量缩宫素促宫颈成熟的效果和安全性[J].中国实用医刊,2022,49(3):58-61.
[13] 王梅,刘德佩,张成思,等.卡贝缩宫素联合Bakri球囊压迫对宫缩乏力性产后出血患者卵巢功能和凝血功能的影响[J].现代生物医学进展,2022,22(2):299-303.
[14] 石雪冬,王方娜,楚伟,等.超声引导下宫内肌内注射西地兰成功复律持续性室上性心动过速胎儿一例[J].中华围产医学杂志,2021, 24(4):267-269.
[15] 高伟波,石茂静,黄文凤,等.59例血栓性血小板减少性紫癜患者临床分析[J].中华急诊医学杂志,2020,29(1):106-111.
[16] 周瑾,俞燮龑.提升宫颈成熟期间应用宫颈双球囊扩张联合小剂量缩宫素的效果和安全性[J].中国妇幼保健,2021,36(13):2993-2995.
[17] 源志群,黄珊珊,彭锦霞.益母草注射液联合缩宫素预防剖宫产产后出血的临床效果及安全性探讨[J].当代医学,2020,26(4):161-162.
[18] 醋红娟,晏春妮,刘科莹.欣母沛加宫腔填塞纱条对凶险型前置胎盘大出血患者止血成功率、不良反应的发生及生育功能的影响[J].贵州医药,2020,44(9):1388-1389.
[19] 倪田田. 间苯三酚联合缩宫素与导乐分娩镇痛仪在足月妊娠引产中的应用价值[J].临床医学研究与实践,2022,7(11):69-71.
[20] 王丹. 马来酸麦角新碱联合缩宫素对阴道分娩产妇产后出血的预防及血流动力学的影响[J].中国妇幼保健,2019,34(21):4894-4897.